BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30507626)

  • 1. Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic Leukemia.
    Moon SY; Lim JH; Kim EH; Nam Y; Yu KS; Hong KT; Choi JY; Hong CR; Kim H; Kang HJ; Shin HY; Lee K; Song J; Lee SY; Song SH
    Ther Drug Monit; 2019 Feb; 41(1):75-85. PubMed ID: 30507626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine.
    Erb N; Harms DO; Janka-Schaub G
    Cancer Chemother Pharmacol; 1998; 42(4):266-72. PubMed ID: 9744770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversed-phase high-performance liquid chromatographic assay method for quantitating 6-mercaptopurine and its methylated and non-methylated metabolites in a single sample.
    Mawatari H; Kato Y; Nishimura S; Sakura N; Ueda K
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):392-6. PubMed ID: 9824258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolites of mercaptopurine in red blood cells: a relationship between 6-thioguanine nucleotides and 6-methylmercaptopurine metabolite concentrations in children with lymphoblastic leukemia.
    Chrzanowska M; Kolecki P; Duczmal-Cichocka B; Fiet J
    Eur J Pharm Sci; 1999 Aug; 8(4):329-34. PubMed ID: 10425383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol to Prevent Mercaptopurine Adverse Effects in Children and Young Adults With Acute Lymphoblastic Leukemia.
    Kamojjala R; Bostrom B
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):95-100. PubMed ID: 33750748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic assay of methylthioguanine nucleotide.
    Rowland K; Lennard L; Lilleyman JS
    J Chromatogr B Biomed Sci Appl; 1998 Jan; 705(1):29-37. PubMed ID: 9498667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic assay of metabolites of thioguanine and mercaptopurine in capillary blood.
    Erb N; Haverland U; Harms DO; Escherich G; Janka-Schaub G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 796(1):87-94. PubMed ID: 14552819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of thiopurine metabolites - a high-performance liquid chromatography method for clinical use.
    Vikingsson S; Almer S; Peterson C; Carlsson B; Josefsson M
    J Pharm Biomed Anal; 2013 Mar; 75():145-52. PubMed ID: 23261807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia.
    Zhang M; Bostrom B
    F1000Res; 2019; 8():176. PubMed ID: 30828444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity.
    Lennard L; Welch JC; Lilleyman JS
    Br J Clin Pharmacol; 1997 Nov; 44(5):455-61. PubMed ID: 9384462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of Concentrations of Azathioprine Metabolites 6-Thioguanine and 6-Methylmercaptopurine in Whole Blood With the Use of Liquid Chromatography Combined With Mass Spectrometry.
    Zochowska D; Zegarska J; Hryniewiecka E; Samborowska E; Jazwiec R; Tszyrsznic W; Borowiec A; Dadlez M; Paczek L
    Transplant Proc; 2016 Jun; 48(5):1836-9. PubMed ID: 27496503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercaptopurine therapy.
    Cuffari C; Seidman EG; Latour S; Théorêt Y
    Can J Physiol Pharmacol; 1996 May; 74(5):580-5. PubMed ID: 8884023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations.
    Lancaster DL; Lennard L; Rowland K; Vora AJ; Lilleyman JS
    Br J Haematol; 1998 Jul; 102(2):439-43. PubMed ID: 9695957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of LC-MS/MS assay for the simultaneous determination of methotrexate, 6-mercaptopurine and its active metabolite 6-thioguanine in plasma of children with acute lymphoblastic leukemia: Correlation with genetic polymorphism.
    Al-Ghobashy MA; Hassan SA; Abdelaziz DH; Elhosseiny NM; Sabry NA; Attia AS; El-Sayed MH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():88-94. PubMed ID: 27802917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPLC determination of thiopurine nucleosides and nucleotides in vivo in lymphoblasts following mercaptopurine therapy.
    Dervieux T; Chu Y; Su Y; Pui CH; Evans WE; Relling MV
    Clin Chem; 2002 Jan; 48(1):61-8. PubMed ID: 11751539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Stability of Thiopurine Metabolites Using a Validated LC-MS/MS Method.
    Yoo IY; Lee K; Ji OJ; Woo HI; Lee SY
    Ann Lab Med; 2018 May; 38(3):255-260. PubMed ID: 29401561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 6-Thioguanine and 6-Mercaptopurine Combination Maintenance Therapy of Childhood ALL: Hypothesis and Case Report.
    Nielsen SN; Frandsen TL; Nersting J; Hjalgrim LL; Schmiegelow K
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):e206-9. PubMed ID: 25171455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of mercaptopurine (6MP) metabolites and 6MP metabolic key-enzymes in childhood acute lymphoblastic leukemia.
    Wojtuszkiewicz A; Barcelos A; Dubbelman B; De Abreu R; Brouwer C; Bökkerink JP; de Haas V; de Groot-Kruseman H; Jansen G; Kaspers GL; Cloos J; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):422-33. PubMed ID: 24940700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol.
    Toksvang LN; Als-Nielsen B; Bacon C; Bertasiute R; Duarte X; Escherich G; Helgadottir EA; Johannsdottir IR; Jónsson ÓG; Kozlowski P; Langenskjöld C; Lepik K; Niinimäki R; Overgaard UM; Punab M; Räty R; Segers H; van der Sluis I; Smith OP; Strullu M; Vaitkevičienė G; Wik HS; Heyman M; Schmiegelow K
    BMC Cancer; 2022 May; 22(1):483. PubMed ID: 35501736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved HPLC method for the quantitation of 6-mercaptopurine and its metabolites in red blood cells.
    Oliveira BM; Romanha AJ; Alves TM; Viana MB; Zani CL
    Braz J Med Biol Res; 2004 May; 37(5):649-58. PubMed ID: 15107925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.